Literature DB >> 19601720

Gender and interindividual variability in pharmacokinetics.

Jean-Marie Nicolas1, Pascal Espie, Mathieu Molimard.   

Abstract

Like any other drugs, antiallergic medications can be associated with large inter- and intraindividual variability in their disposition. The best-documented examples belong to the H1 antihistamines. Variable drugs are more likely to show unpredictable therapeutic response with both increased risks of side effects and subtherapeutic dosing in individual subjects. This article will review the main factors contributing to intervariability in pharmacokinetics with a special emphasis on gender differences, genetic polymorphism, and food habits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601720     DOI: 10.1080/10837450902891485

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  20 in total

Review 1.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

2.  Predicted metabolic drug clearance with increasing adult age.

Authors:  Thomas M Polasek; Farhaan Patel; Berit P Jensen; Michael J Sorich; Michael D Wiese; Matthew P Doogue
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

Review 3.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

Review 4.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

5.  Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study.

Authors:  Rohan Gurjar; Laura Dickinson; Daniel Carr; Wolfgang Stöhr; Stefano Bonora; Andrew Owen; Antonio D'Avolio; Adam Cursley; Nathalie De Castro; Gerd Fätkenheuer; Linos Vandekerckhove; Giovanni Di Perri; Anton Pozniak; Christine Schwimmer; François Raffi; Marta Boffito
Journal:  Pharmacogenomics J       Date:  2022-10-20       Impact factor: 3.245

6.  High-dose quetiapine and therapeutic monitoring.

Authors:  Hervé Javelot; Francis Rangoni; Luisa Weiner; Bruno Michel
Journal:  Eur J Hosp Pharm       Date:  2018-08-06

7.  Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.

Authors:  Mona Arab-Alameddine; Aurélie Fayet-Mello; Rubin Lubomirov; Michael Neely; Julia di Iulio; Andrew Owen; Marta Boffito; Matthias Cavassini; Huldrych F Günthard; Katharina Rentsch; Thierry Buclin; Manel Aouri; Amalio Telenti; Laurent Arthur Decosterd; Margalida Rotger; Chantal Csajka
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

8.  Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.

Authors:  Richard A Larson; Ophelia Q P Yin; Andreas Hochhaus; Giuseppe Saglio; Richard E Clark; Hirohisa Nakamae; Neil J Gallagher; Eren Demirhan; Timothy P Hughes; Hagop M Kantarjian; Philipp D le Coutre
Journal:  Eur J Clin Pharmacol       Date:  2011-12-30       Impact factor: 2.953

Review 9.  Sex differences in drug disposition.

Authors:  Offie P Soldin; Sarah H Chung; Donald R Mattison
Journal:  J Biomed Biotechnol       Date:  2011-02-23

10.  Gender-specific asthma treatment.

Authors:  Inseon S Choi
Journal:  Allergy Asthma Immunol Res       Date:  2010-11-08       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.